Free Sexual harassment reporting structures in oncology are broken, The Cancer Letter survey finds October 02, 2020Vol.46 No.37By Alexandria Carolan, Katie Goldberg and Matthew Bin Han Ong
Drugs & TargetsFree Innova Therapeutics receives Rare Pediatric Disease Designation from FDA for IVT-8086 for Osteosarcoma October 02, 2020Vol.46 No.37
Drugs & TargetsFree Celyad Oncology collaborates with MSD to evaluate CYAD-101 with Keytruda in microsatellite stable mCRC October 02, 2020Vol.46 No.37
Drugs & TargetsFree University of Illinois scientists enter licensing deal with Bayer, Systems Oncology October 02, 2020Vol.46 No.37
Drugs & TargetsFree Elevation Oncology and US Oncology Research collaborate to expand genomic testing of solid tumors October 02, 2020Vol.46 No.37
Clinical RoundupFree Corticosteroids improve survival in critically ill COVID-19 patients October 02, 2020Vol.46 No.37
Clinical RoundupFree Phase III trial shows Opdivo significantly improves DFS as adjuvant therapy for muscle-invasive urothelial carcinoma October 02, 2020Vol.46 No.37
Clinical RoundupFree Yale study reinforces benefit of using targeted therapy for early-stage NSCLC October 02, 2020Vol.46 No.37
FreeTrials & Tribulations The cancer detection rate—a public health approach to early detection October 02, 2020Vol.46 No.37By Joshua J. Ofman and Azra Raza
